UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year revenue growth.

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath Inc PATH reported financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. Here’s a look at the key details from the report. UiPath shares are advancing ...

The Wikimedia Foundation suffered a security incident today after a self-propagating JavaScript worm began vandalizing pages and modifying user scripts across multiple wikis.

Marketeam.ai is building the first Integrated Marketing Environment (IME) - think of it like an IDE for marketing, but proactive. Instead of fragmented tools and dashboards, it runs marketing as a ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Quadratic regression is a classical machine learning technique to predict a single numeric value. Quadratic regression is an extension of basic linear regression. Quadratic regression can deal with ...

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.